Jin & Investment Partners logo

Jin & Investment Partners

Asia, Kyonggi-do, South Korea, Seongnam

Description

Jin & Investment Partners is an investment company that specializes in digital health care.

Investor Profile

Jin & Investment Partners has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C rounds (top funding stages).
  • Majority of deals are located in South Korea.
  • Strong thematic focus on Biotechnology, Medical, Pharmaceutical.

Stage Focus

  • Series C (100%)

Country Focus

  • South Korea (100%)

Industry Focus

  • Biotechnology
  • Medical
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Jin & Investment Partners frequently co-invest with?

Lead Compass Investment
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 1
TNC Asset Management
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Elohim Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
GC
North America, California, United States, San Francisco
Co-Investments: 1
Cytogen
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
eBEST
Asia, Seoul-t'ukpyolsi, South Korea, Yongdungpo
Co-Investments: 1
Seoul Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Magellan Technology Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by Jin & Investment Partners?

Trioar

Daejeon, Taejon-jikhalsi, South Korea

Trioar is a biotechnological research company that manufacture pharmaceutical products and drugs.

BiopharmaBiotechnologyPharmaceutical
Series BJul 17, 2025
Amount Raised: $16,163,094
Wellmarker Bio

Seoul, Seoul-t'ukpyolsi, South Korea

Wellmarker Bio Co., Ltd. is the first spin off company.

BiotechnologyMedicalPharmaceutical
Series COct 14, 2021
Amount Raised: $11,840,842